Objective: To compare the health and economic impacts of implementing efficacious treatment interventions with maintaining standard practice in maternal and perinatal health care.
Design and setting: We identified randomised clinical trials (RCTs) in the Perinatal Society of Australia and New Zealand trials database that commenced recruitment during 2008 and had completed recruitment by 2015. Data from clinical trial registries and publications were collated to calculate the potential cost savings achievable by implementing efficacious treatment interventions.
Main outcome measure: Projected net cost savings over 5 years.
Results: Twenty-three eligible RCTs covering a range of behavioural and clinical interventions were identified, of which six reported interventions superior to standard practice (four trials) or placebo (two). The outcomes (but not the costs) of 17 trials were excluded from analysis (no difference between intervention and comparator groups in seven trials, recruitment problems in six, findings not yet published in four). The total funding amount for the 23 trials was $20.3 million; the potential cost savings over 5 years if the findings of the six trials reporting superior interventions were implemented was estimated to be $26.3 million if 10% of the eligible populations received the effective interventions, and $262.8 million with 100% implementation.
Conclusions: Our retrospective analysis highlights the value of research in perinatal care and the importance of implementing positive findings for realising its value. Future trials in maternal and perinatal health care may provide significant returns on investment by informing clinical practice, improving patient outcomes and reducing health care costs.
- 1. Johnston SC, Rootenberg JD, Katrak S, et al. Effect of a US National Institutes of Health programme of clinical trials on public health and costs. Lancet 2006; 367: 1319-1327.
- 2. Deloitte Access Economics, for the Australian Society for Medical Research. Returns on NHMRC funded research and development. Canberra: Deloitte Access Economics, 2011. https://asmr.org.au/wp-content/uploads/library/NHMRCReturns.pdf (accessed July 2017).
- 3. Guthrie S, Hafner M, Bienkowska-Gibbs T, Wooding S. Returns on research funded under the NIHR Health Technology Assessment (HTA) Programme: economic analyses and case studies. Santa Monica: RAND Corporation, 2015. http://www.rand.org/pubs/research_reports/RR666.html (accessed July 2017).
- 4. van’ t Hooft J, Opmeer BC, Teune MJ, et al. Kosten en effecten van doelmatigheidsonderzoek in de obstetrie. Een budget-impactanalyse van 8 obstetrische doelmatigheidsstudies. Ned Tijdschr Geneeskd 2013; 157: A6287.
- 5. Australian Research Centre for Health of Women and Babies. The WOMBAT Collaboration. 2005–2010 [webpage]. https://www.adelaide.edu.au/arch/research/res_network/WOMBAT/ (accessed July 2017).
- 6. Maycock B, Binns CW, Dhaliwal S, et al. Education and support for fathers improves breastfeeding rates: a randomized controlled trial. J Hum Lact 2013; 29: 484-490.
- 7. Harrison CL, Lombard CB, Strauss BJ, Teede HJ. Optimizing healthy gestational weight gain in women at high risk of gestational diabetes: a randomized controlled trial. Obesity (Silver Spring) 2013; 21: 904-909.
- 8. Campbell KJ, Lioret S, McNaughton SA, et al. A parent-focused intervention to reduce infant obesity risk behaviors: a randomized trial. Pediatrics 2013; 131: 652-660.
- 9. Tracy SK, Hartz DL, Tracy MB, et al. Caseload midwifery care versus standard maternity care for women of any risk: M@NGO, a randomised controlled trial. Lancet 2013; 382: 1723-1732.
- 10. Belavy D, Cowlishaw PJ, Howes M, Phillips F. Ultrasound-guided transversus abdominis plane block for analgesia after Caesarean delivery. Br J Anaesth 2009; 103: 726-730.
- 11. Harris DL, Weston PJ, Signal M, et al. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. Lancet 2013; 382: 2077-2083.
- 12. Australian Institute of Health and Welfare. Australia’s health 2012 (AIHW Cat. No. AUS 156; Australia’s Health Series No. 13). Canberra: AIHW, 2012.
- 13. Hilder L, Zhichao Z, Parker M, et al. Australia’s mothers and babies 2012 (AIHW Cat. No. PER 69; Perinatal Statistics Series No. 30). Canberra: Australian Institute of Health and Welfare, 2014.
- 14. Australian Bureau of Statistics. 3101.0. Australian demographic statistics, Jun 2012. Population by age and sex tables. Updated March 2013. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/3101.0Main+Features1Jun%202012?OpenDocument (accessed July 2017).
- 15. Australian Bureau of Statistics. 4906.0. Personal safety, Australia, 2012. Dec 2013. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4906.0Chapter3002012 (accessed Sept 2015).
- 16. Brand-Miller J. Obesity in pregnancy [online article]. Obesity Australia; Apr 2013. Archived: https://web.archive.org/web/20160315095132/http://www.obesityaustralia.org/general-public-fact-sheets/obesity-in-pregnancy (accessed July 2017).
- 17. Hay WW, Raju TN, Higgins RD, et al. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr 2009; 155: 612-617.
- 18. Australian Bureau of Statistics. 4364.0.55.001. Australian health survey: first results, 2011–12. Oct 2012. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/4364.0.55.001main+features12011-12 (accessed Sept 2015).
- 19. Aspen Nutritionals Australia. S-26 Gold Newborn [website]. Me and my child; undated. http://www.meandmychild.com.au/products/s-26-gold-newborn/ (accessed July 2017).
- 20. Moss JR, Crowther CA, Hiller JE, et al. Costs and consequences of treatment for mild gestational diabetes mellitus — evaluation from the ACHOIS randomised trial. BMC Pregnancy Childbirth 2007; 7: 27.
- 21. Independent Hospital Pricing Authority. National Hospital Cost Data Collection. Australian public hospitals cost report 2012–2013, round 17. Commonwealth of Australia, 2015. https://www.ihpa.gov.au/sites/g/files/net636/f/publications/nhcdc_cost_report_2012-2013_round_17_0.pdf (accessed May 2016).
- 22. Royal Women’s Hospital. Patient fees: patients who do not have a Medicare card. [webpage]. Undated. https://www.thewomens.org.au/patients-visitors/patient-fees/ (accessed May 2016).
- 23. Pharmaceutical Benefits Advisory Committee. Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (version 5.0). Canberra: Australian Government Department of Health, 2016. https://pbac.pbs.gov.au/content/information/files/pbac-guidelines-version-5.pdf (accessed July 2017).
- 24. National Health and Medical Research Council. Health and medical research and the future in NHMRC’s 75th year. The virtuous cycle and the economic benefits of health and medical research [discussion paper]. Canberra: NHMRC, 2011. https://www.nhmrc.gov.au/_files_nhmrc/file/about/senior_staff/articles/economic_benefits_health_research_wa_110909.pdf (accessed July 2017).
- 25. National Health and Medical Research Council. Infant feeding guidelines: summary. Canberra: NHMRC, 2013. https://www.nhmrc.gov.au/_files_nhmrc/file/publications/170131_n56_infant_feeding_guidelines_summary.pdf (accessed July 2017).
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.